Pulmonary Alveolar Microlithiasis: A Unique Case of Familial PAM Complicated by Transplant Rejection.

IF 0.7 Q4 PATHOLOGY
Case Reports in Pathology Pub Date : 2021-04-05 eCollection Date: 2021-01-01 DOI:10.1155/2021/6674173
Austin Helmink, Samir Atiya, Ernesto Martinez Duarte
{"title":"Pulmonary Alveolar Microlithiasis: A Unique Case of Familial PAM Complicated by Transplant Rejection.","authors":"Austin Helmink,&nbsp;Samir Atiya,&nbsp;Ernesto Martinez Duarte","doi":"10.1155/2021/6674173","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pulmonary alveolar microlithiasis (PAM) is a rare lung disease characterized by the deposition of calcium phosphate microliths or calcospherites, within the alveolar airspace. Typical imaging findings demonstrate a \"sandstorm\" appearance due to bilateral, interstitial sand-like micronodularities with basal predominance.</p><p><strong>Methods and results: </strong>We describe an unusual case of a 48-year-old male with severe, familial PAM ultimately treated with a bilateral lung transplant.</p><p><strong>Conclusions: </strong>PAM is a rare lung disease caused by a mutation in the <i>SLC34A2</i> gene, which encodes for a sodium-phosphate cotransporter in type II alveolar cells, leading to accumulation of intra-alveolar phosphate causing microlith formation. PAM has an indolent course but can progress to chronic hypoxic respiratory failure, ultimately requiring lung transplant, the only known effective treatment.</p>","PeriodicalId":45638,"journal":{"name":"Case Reports in Pathology","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2021-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041554/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2021/6674173","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 2

Abstract

Background: Pulmonary alveolar microlithiasis (PAM) is a rare lung disease characterized by the deposition of calcium phosphate microliths or calcospherites, within the alveolar airspace. Typical imaging findings demonstrate a "sandstorm" appearance due to bilateral, interstitial sand-like micronodularities with basal predominance.

Methods and results: We describe an unusual case of a 48-year-old male with severe, familial PAM ultimately treated with a bilateral lung transplant.

Conclusions: PAM is a rare lung disease caused by a mutation in the SLC34A2 gene, which encodes for a sodium-phosphate cotransporter in type II alveolar cells, leading to accumulation of intra-alveolar phosphate causing microlith formation. PAM has an indolent course but can progress to chronic hypoxic respiratory failure, ultimately requiring lung transplant, the only known effective treatment.

Abstract Image

Abstract Image

肺泡微石症:家族性PAM合并移植排斥的独特病例。
背景:肺泡微石症(PAM)是一种罕见的肺部疾病,其特征是在肺泡腔内沉积磷酸钙微石或钙球粒。典型影像学表现为双侧间质沙样微结节,呈“沙暴”状,基底为主。方法和结果:我们描述了一个不寻常的情况下,48岁的男性严重,家族性PAM最终治疗与双侧肺移植。结论:PAM是一种罕见的肺部疾病,由SLC34A2基因突变引起,该基因编码II型肺泡细胞中的磷酸钠共转运体,导致肺泡内磷酸盐积聚导致微石形成。PAM病程缓慢,但可发展为慢性缺氧性呼吸衰竭,最终需要肺移植,这是唯一已知的有效治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
20
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信